Capivasertib in combination with fulvestrant: New treatment options for HR + /HER2 −  metastatic breast cancer

A. L. Kornietskaya; L. V. Bolotina; S. F. Evdokimova; N. S. Prizova; Yu. B. Karagodina

Meditsinskiy sovet = Medical Council
Meditsinskiy sovet

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

User

eng | рус

Meditsinskiy sovet = Medical Council

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Kornietskaya AL, Bolotina LV, Evdokimova SF, Prizova NS, Karagodina YB. Capivasertib in combination with fulvestrant: New treatment options for HR⁺/HER2⁻ metastatic breast cancer. Meditsinskiy sovet = Medical Council. 2025;(21):52-59. (In Russ.) https://doi.org/10.21518/ms2025-543

Views PDF (Rus): 11

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

Editor-in-Chief

Aydar A. Ishmukhametov

* not an advertisement

По рекомендации Президиума ВАК от 8 декабря 2023 г. № 31/1-разн

"О категорировании перечня рецензируемых научных изданий, в которых должны быть опубликованы основные научные результаты диссертаций на соискание ученой степени кандидата наук, на соискание ученой степени доктора наук" журналу «Медицинский совет» присвоена категория К1

Popular articles

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. L. Kornietskaya
Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Center
Russian Federation

Аnna L. Kornietskaya - Cand. Sci. (Med.), Leading Researcher of the Department of Drug Treatment of Tumors, Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Center.